Physician profile
Elena Edwards
NPI 1568524098
$9,697.95
in general payments reported to CMS, 2019-2025
58 companies · $139 in 2025
The $139 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,769 · 2020: $2,115 · 2021: $2,433 · 2022: $2,379 · 2023: $692 · 2024: $170 · 2025: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,002.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,001.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,747.12 | 2019-2024 | Vraylar, Creon, Linzess |
| Novo Nordisk INC | $726.09 | 2019-2025 | Wegovy |
| Allergan, INC. | $667.88 | 2019-2020 | |
| Pfizer INC. | $494.86 | 2019-2024 | |
| Amarin Pharma, INC. | $474.60 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $391.77 | 2019-2023 | Farxiga, Breztri |
| Lilly USA, LLC | $386.48 | 2019-2023 | Trulicity, Mounjaro, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $376.61 | 2019-2023 | Jardiance, Tradjenta |
| Amgen INC. | $342.18 | 2019-2023 | Prolia, Evenity, Otezla |
| Bayer Healthcare Pharmaceuticals INC. | $318.34 | 2021-2023 | |
| Janssen Pharmaceuticals, INC | $293.79 | 2019-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $291.64 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $290.07 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $218.12 | 2020-2022 | |
| E.R. Squibb & Sons, L.L.C. | $199.44 | 2019-2023 | Eliquis |
Show all 58 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elena Edwards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.